Cargando…
High-mobility group box chromosomal protein-1 deletion alleviates osteoporosis in OVX rat model via suppressing the osteoclastogenesis and inflammation
BACKGROUND: Osteoporosis is a skeletal metabolic disease that constitutes a great threaten to human health. However, there is currently no gold standard for its treatment. High-mobility group box chromosomal protein-1 (HMGB-1) has been reported to play an important role in various orthopedic disease...
Autores principales: | Yu, Haotao, Zhou, Wei, Zhong, Zhihong, Qiu, Ruixin, Chen, Guoquan, Zhang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004163/ https://www.ncbi.nlm.nih.gov/pubmed/35414033 http://dx.doi.org/10.1186/s13018-022-03110-8 |
Ejemplares similares
-
Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress
por: Ding, Lingli, et al.
Publicado: (2023) -
Comparison of Necroptosis With Apoptosis for OVX-Induced Osteoporosis
por: He, Bin, et al.
Publicado: (2021) -
Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
por: Hong, Guoju, et al.
Publicado: (2020) -
The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice
por: Li, Xiang, et al.
Publicado: (2019) -
Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
por: Lin, Wei, et al.
Publicado: (2021)